Ocugen (OCGN) Invested Capital (2014 - 2026)
Ocugen (OCGN) reported Invested Capital of $7.5 million for Q1 2026, down 82.07% on a YoY basis from $42.0 million in Q1 2025, and up 171.85% quarter-over-quarter from -$10.5 million in Q4 2025.
Ocugen (OCGN) Invested Capital (2014 - 2026) Analysis & Trends
Ocugen has reported Invested Capital for 13 years, with the latest figure at $7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital fell 82.07% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (down 82.07% YoY), and the FY2025 full-year result was -$10.5 million, down 118.91% from the prior year.
- Invested Capital for Q1 2026 stood at $7.5 million, up from -$10.5 million in the prior quarter.
- The five-year high for Invested Capital was $127.2 million in Q1 2022, with the low at -$10.5 million in Q4 2025.
- Historically, Invested Capital has averaged $48.6 million across 5 years, with a median of $43.5 million in 2024.
- Annual changes were most pronounced in 2022 — Invested Capital surged 162.01% — and 2025, when it plunged 118.91%.
- Ocugen's Invested Capital stood at $76.3 million in 2022, then slumped by 43.14% to $43.4 million in 2023, then climbed by 27.73% to $55.4 million in 2024, then sank by 118.91% to -$10.5 million in 2025, then soared by 171.85% to $7.5 million in 2026.
- The last three Invested Capital figures came in at $7.5 million (Q1 2026), -$10.5 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 7.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.53 Mn |
| Dec 31, 2025 | -10.48 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | 41.98 Mn |
| Dec 31, 2024 | 55.39 Mn |
| Sep 30, 2024 | 43.52 Mn |
| Jun 30, 2024 | 19.79 Mn |
| Mar 31, 2024 | 33.09 Mn |
| Dec 31, 2023 | 43.36 Mn |
| Sep 30, 2023 | 52.57 Mn |
| Jun 30, 2023 | 61.98 Mn |
| Mar 31, 2023 | 67.22 Mn |
| Dec 31, 2022 | 76.27 Mn |
| Sep 30, 2022 | 87.95 Mn |
| Jun 30, 2022 | 108.23 Mn |
| Mar 31, 2022 | 127.25 Mn |
| Dec 31, 2021 | 92.91 Mn |
| Sep 30, 2021 | 108.80 Mn |
| Jun 30, 2021 | 118.08 Mn |